To complete these results of the roles of E-cadherin, β-catenin, Col I, Col III, Col V, WNT1, and WNT5B in NSCLC, we explored, in silico, whether the mRNA level of these proteins related to clinical outcome of the patients. This evidence concerns the gene CDH1 and non-small cell lung carcinoma.